{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T15:14:24Z","timestamp":1780067664103,"version":"3.54.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,2]],"date-time":"2022-08-02T00:00:00Z","timestamp":1659398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,8,2]],"date-time":"2022-08-02T00:00:00Z","timestamp":1659398400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Interv and Ther"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1007\/s12928-022-00877-9","type":"journal-article","created":{"date-parts":[[2022,8,2]],"date-time":"2022-08-02T19:12:13Z","timestamp":1659467533000},"page":"64-74","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Vascular healing in high-bleeding-risk patients at 3-month after everolimus-eluting stent versus biolimus A9-coated stent implantation: insights from analysis of optical coherence tomography and coronary angioscopy"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2093-8165","authenticated-orcid":false,"given":"Hiroshi","family":"Koiwaya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensaku","family":"Nishihira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosuke","family":"Kadooka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nehiro","family":"Kuriyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshisato","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,2]]},"reference":[{"key":"877_CR1","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1056\/NEJM199812033392303","volume":"339","author":"MB Leon","year":"1998","unstructured":"Leon MB, Baim DS, Popma JJ, Gordon PC, Cutlip DE, Ho KK, et al. A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators. N Engl J Med. 1998;339:1665\u201371.","journal-title":"N Engl J Med"},{"key":"877_CR2","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.jacc.2009.07.019","volume":"54","author":"E Nikolsky","year":"2009","unstructured":"Nikolsky E, Stone GW, Kirtane AJ, George SM, Lansky AJ, McLaurin B, et al. Gastrointestinal bleeding in patients with acute coronary syndromes: Incidence, predictors, and clinical implications. J Am Coll Cardiol. 2009;54:1293\u2013302.","journal-title":"J Am Coll Cardiol"},{"key":"877_CR3","doi-asserted-by":"publisher","first-page":"e008708","DOI":"10.1161\/JAHA.118.008708","volume":"7","author":"M Natsuaki","year":"2018","unstructured":"Natsuaki M, Morimoto T, Yamaji K, Watanabe H, Yoshikawa Y, Shiomi H, et al. Prediction of thrombotic and bleeding events after percutaneous coronary intervention: CREDO-Kyoto thrombotic and bleeding risk scores. J Am Heart Assoc. 2018;7:e008708.","journal-title":"J Am Heart Assoc"},{"key":"877_CR4","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/eurheartj\/ehx419","volume":"39","author":"M Valgimigli","year":"2018","unstructured":"Valgimigli M, Bueno H, Byrne RA, Collet JP, Costa F, Jeppsson A, et al. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS. Eur Heart J. 2018;39:213\u201360.","journal-title":"Eur Heart J"},{"key":"877_CR5","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1253\/circj.CJ-19-0133","volume":"83","author":"K Kimura","year":"2019","unstructured":"Kimura K, Kimura T, Ishihara M, Nakagawa Y, Nakao K, Miyauchi K, et al. JCS 2018 guideline on diagnosis and treatment of acute coronary syndrome. Circ J. 2019;83:1085\u2013196.","journal-title":"Circ J"},{"key":"877_CR6","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/j.jcin.2013.06.015","volume":"6","author":"T Tada","year":"2013","unstructured":"Tada T, Byrne RA, Simunovic I, King LA, Cassese S, Joner M, et al. Risk of stent thrombosis among bare-metal stents, first-generation drug-eluting stents, and second-generation drug-eluting stents: results from a registry of 18334 patients. J Am Coll Cardiol Intv. 2013;6:1267\u201374.","journal-title":"J Am Coll Cardiol Intv"},{"key":"877_CR7","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1007\/s12928-015-0366-9","volume":"31","author":"M Natsuaki","year":"2016","unstructured":"Natsuaki M, Morimoto T, Yamamoto E, Shiomi H, Furukawa Y, Abe M, et al. One-year outcome of a prospective trial stopping dual antiplatelet therapy at 3 months after everolimus-eluting cobalt-chromium stent implantation: Short and optimal duration of dual antiplatelet therapy after everolimus-eluting cobalt-chromium stent (STOPDAPT) trial. Cardiovasc Interv Ther. 2016;31:196\u2013209.","journal-title":"Cardiovasc Interv Ther"},{"key":"877_CR8","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1056\/NEJMoa1503943","volume":"373","author":"P Urban","year":"2015","unstructured":"Urban P, Meredith IT, Abizaid A, Pocock SJ, Carri\u00e9 D, Naber C, et al. Polymer-free drug-coated coronary stents in patients at high bleeding risk. N Engl J Med. 2015;373:2038\u201347.","journal-title":"N Engl J Med"},{"key":"877_CR9","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","volume":"123","author":"R Mehran","year":"2011","unstructured":"Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J, et al. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation. 2011;123:2736\u201347.","journal-title":"Circulation"},{"key":"877_CR10","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s12928-020-00653-7","volume":"35","author":"N Suzuki","year":"2020","unstructured":"Suzuki N, Asano T, Nakazawa G, Aoki J, Tanabe K, Hibi K, et al. Clinical expert consensus document on quantitative coronary angiography from the Japanese Association of Cardiovascular Intervention and Therapeutics. Cardiovasc Interv Ther. 2020;35:105\u201316.","journal-title":"Cardiovasc Interv Ther"},{"key":"877_CR11","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/0735-1097(94)90417-0","volume":"23","author":"Y Ueda","year":"1994","unstructured":"Ueda Y, Nanto S, Komamura K, Kodama K. Neointimal coverage of stents in human coronary arteries observed by angioscopy. J Am Coll Cardiol. 1994;23:341\u20136.","journal-title":"J Am Coll Cardiol"},{"key":"877_CR12","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1007\/s10554-019-01580-2","volume":"35","author":"S Suzuki","year":"2019","unstructured":"Suzuki S, Sotomi Y, Kobayashi T, Hamanaka Y, Nakatani S, Shiojima I, et al. Early vessel healing after implantation of biodegradable-polymer and durable-polymer drug-eluting stent: 3-month angioscopic evaluation of the RESTORE registry. Int J Cardiovasc Imaging. 2019;35:973\u201380.","journal-title":"Int J Cardiovasc Imaging"},{"key":"877_CR13","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1016\/j.jacc.2005.11.092","volume":"47","author":"J Kotani","year":"2006","unstructured":"Kotani J, Awata M, Nanto S, Uematsu M, Oshima F, Minamiguchi H, et al. Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings. J Am Coll Cardiol. 2006;47:2108\u201311.","journal-title":"J Am Coll Cardiol"},{"key":"877_CR14","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s12928-021-00770-x","volume":"37","author":"Y Mitsutake","year":"2022","unstructured":"Mitsutake Y, Yano H, Ishihara T, Matsuoka H, Ueda Y, Ueno T. Consensus document on the standard of coronary angioscopy examination and assessment from the Japanese Association of Cardiovascular Intervention and Therapeutics. Cardiovasc Interv Ther. 2022;37:35\u20139.","journal-title":"Cardiovasc Interv Ther"},{"key":"877_CR15","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1016\/S0735-1097(01)01673-4","volume":"38","author":"Y Ueda","year":"2001","unstructured":"Ueda Y, Asakura M, Yamaguchi O, Hirayama A, Hori M, Kodama K. The healing process of infarct-related plaques. Insights from 18 months of serial angioscopic follow-up. J Am Coll Cardiol. 2001;38:1916\u201322.","journal-title":"J Am Coll Cardiol"},{"key":"877_CR16","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.jcin.2014.12.239","volume":"8","author":"Y Ueda","year":"2015","unstructured":"Ueda Y, Matsuo K, Nishimoto Y, Sugihara R, Hirata A, Nemoto T. In-stent yellow plaque at 1 year after implantation is associated with future event of very late stent failure. The DESNOTE study. J Am Coll Cardiol Intv. 2015;8:814\u201321.","journal-title":"J Am Coll Cardiol Intv"},{"key":"877_CR17","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1253\/circj.CJ-13-1474","volume":"78","author":"A Konishi","year":"2014","unstructured":"Konishi A, Shinke T, Otake H, Takaya T, Nakagawa M, Inoue T, et al. Favorable vessel healing after nobori biolimus A9-eluting stent implantation-6- and 12-month follow-up by optical coherence tomography. Circ J. 2014;78:1882\u201390.","journal-title":"Circ J"},{"key":"877_CR18","doi-asserted-by":"publisher","first-page":"564","DOI":"10.4244\/EIJV11I5A109","volume":"11","author":"T Kubo","year":"2015","unstructured":"Kubo T, Akasaka T, Kozuma K, Kimura K, Kawamura M, Sumiyoshi T, et al. Comparison of neointimal coverage between everolimus-eluting stents and sirolimus-eluting stents: an optical coherence tomography substudy of the RESET (Randomized Evaluation of Sirolimus-eluting versus Everolimus-eluting stent Trial). EuroIntervention. 2015;11:564\u201371.","journal-title":"EuroIntervention"},{"key":"877_CR19","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s12928-019-00626-5","volume":"35","author":"K Fujii","year":"2020","unstructured":"Fujii K, Kubo T, Otake H, Nakazawa G, Sonoda S, Hibi K, et al. Expert consensus statement for quantitative measurement and morphological assessment of optical coherence tomography. Cardiovasc Interv Ther. 2020;35:13\u20138.","journal-title":"Cardiovasc Interv Ther"},{"key":"877_CR20","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1093\/eurheartj\/ehl413","volume":"28","author":"D Matsumoto","year":"2007","unstructured":"Matsumoto D, Shite J, Shinke T, Otake H, Tanino Y, Ogasawara D, et al. Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: evaluated by optical coherence tomography. Eur Heart J. 2007;28:961\u20137.","journal-title":"Eur Heart J"},{"key":"877_CR21","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1253\/circj.CJ-09-0690","volume":"74","author":"N Miyoshi","year":"2010","unstructured":"Miyoshi N, Shite J, Shinke T, Otake H, Tanino Y, Ogasawara D, et al. Comparison by optical coherence tomography of paclitaxel-eluting stents with sirolimus-eluting stents implanted in one coronary artery in one procedure\u20146-month follow-up. Circ J. 2010;74:903\u20138.","journal-title":"Circ J"},{"key":"877_CR22","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1093\/eurheartj\/ehz372","volume":"40","author":"P Urban","year":"2019","unstructured":"Urban P, Mehran R, Colleran R, Angiolillo DJ, Byrne RA, Capodanno D, et al. Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for high bleeding risk. Eur Heart J. 2019;40:2632\u201353.","journal-title":"Eur Heart J"},{"key":"877_CR23","doi-asserted-by":"publisher","first-page":"e008307","DOI":"10.1161\/CIRCINTERVENTIONS.119.008307","volume":"12","author":"M Natsuaki","year":"2019","unstructured":"Natsuaki M, Morimoto T, Shiomi H, Yamaji K, Watanabe H, Shizuta S, et al. Application of the Academic Research Consortium high bleeding risk criteria in an all-comers registry of percutaneous coronary intervention. Circ Cardiovasc Interv. 2019;12:e008307.","journal-title":"Circ Cardiovasc Interv"},{"key":"877_CR24","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1161\/CIRCULATIONAHA.117.026788","volume":"136","author":"T Adriaenssens","year":"2017","unstructured":"Adriaenssens T, Joner M, Godschalk TC, Malik N, Alfonso F, Xhepa E, et al. Optical coherence tomography findings in patients with coronary stent thrombosis: a report of the PRESTIGE consortium. Circulation. 2017;136:1007\u201321.","journal-title":"Circulation"},{"key":"877_CR25","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1016\/j.jacc.2018.02.023","volume":"71","author":"J Torrado","year":"2018","unstructured":"Torrado J, Buckley L, Dur\u00e1n A, Trujillo P, Toldo S, Raleigh JV, et al. Restenosis, stent thrombosis, and bleeding complications. J Am Coll Cardiol. 2018;71:1676\u201395.","journal-title":"J Am Coll Cardiol"},{"key":"877_CR26","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1253\/circj.CJ-10-0776","volume":"75","author":"M Awata","year":"2011","unstructured":"Awata M, Uematsu M, Sera F, Ishihara T, Watanabe T, Fujita M, et al. Angioscopic assessment of arterial repair following biodegradable polymer-coated biolimus A9-eluting stent implantation. Circ J. 2011;75:1113\u20139.","journal-title":"Circ J"},{"key":"877_CR27","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1093\/ehjci\/jes183","volume":"14","author":"M Habara","year":"2013","unstructured":"Habara M, Terashima M, Nasu K, Kaneda H, Yokota D, Ito T, et al. Morphological differences of tissue characteristics between early, late, and very late restenosis lesions after first generation drug-eluting stent implantation: an optical coherence tomography study. Eur Heart J Cardiovasc Imaging. 2013;14:276\u201384.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"877_CR28","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1007\/s10554-013-0223-9","volume":"29","author":"H Won","year":"2013","unstructured":"Won H, Shin DH, Kim BK, Mintz GS, Kim JS, Ko TG, et al. Optical coherence tomography derived cut-off value of uncovered stent struts to predict adverse clinical outcomes after drug-eluting stent implantation. Int J Cardiovasc Imaging. 2013;29:1255\u201363.","journal-title":"Int J Cardiovasc Imaging"},{"key":"877_CR29","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1161\/CIRCRESAHA.117.310275","volume":"120","author":"Y Sotomi","year":"2017","unstructured":"Sotomi Y, Onuma Y, Collet C, Tenekecioglu E, Virmani R, Kleiman NS, et al. Bioresorbable scaffold the emerging reality and future directions. Circ Res. 2017;120:1341\u201352.","journal-title":"Circ Res"},{"key":"877_CR30","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1161\/STROKEAHA.107.504993","volume":"39","author":"K Toyoda","year":"2008","unstructured":"Toyoda K, Yasaka M, Iwade K, Nagata K, Koretsune Y, Sakamoto T, et al. Dual antithrombotic therapy increases severe bleeding events in patients with stroke and cardiovascular disease: a prospective, multicenter, observational study. Stroke. 2008;39:1740\u20135.","journal-title":"Stroke"},{"key":"877_CR31","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1016\/j.jcin.2015.08.018","volume":"8","author":"LR Jackson","year":"2015","unstructured":"Jackson LR, Ju C, Zettler M, Messenger JC, Cohen DJ, Stone GW, et al. Outcomes of patients with acute myocardial infarction undergoing percutaneous coronary intervention receiving an oral anticoagulant and dual antiplatelet therapy: a comparison of clopidogrel versus prasugrel from the TRANSLATE-ACS Study. J Am Coll Cardiol Intv. 2015;8:1880\u20139.","journal-title":"J Am Coll Cardiol Intv"},{"key":"877_CR32","doi-asserted-by":"publisher","first-page":"010144","DOI":"10.1161\/CIRCINTERVENTIONS.120.010144","volume":"14","author":"AJ Kirtane","year":"2021","unstructured":"Kirtane AJ, Stoler R, Feldman R, Neumann FJ, Boutis L, Tahirkheli N, et al. Primary results of the EVOLVE Short DAPT Study: evaluation of 3-month dual antiplatelet therapy in high bleeding risk patients treated with a bioabsorbable polymer-coated everolimus-eluting stent. Circ Cardiovasc Interv. 2021;14:010144.","journal-title":"Circ Cardiovasc Interv"}],"container-title":["Cardiovascular Intervention and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12928-022-00877-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12928-022-00877-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12928-022-00877-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,8]],"date-time":"2023-01-08T01:09:35Z","timestamp":1673140175000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12928-022-00877-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,2]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["877"],"URL":"https:\/\/doi.org\/10.1007\/s12928-022-00877-9","relation":{},"ISSN":["1868-4300","1868-4297"],"issn-type":[{"value":"1868-4300","type":"print"},{"value":"1868-4297","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,2]]},"assertion":[{"value":"4 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there are no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Approval number 2018-43.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institution Review Board of Miyazaki Medical Association Hospital"}}]}}